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Abstract. Breast mimicking tissue optical phantoms with sufficient structural integrity to be deployed as stand-
alone imaging targets are developed and successfully constructed with biologically relevant concentrations of
water, lipid, and blood. The results show excellent material homogeneity and reproducibility with inter- and intra-
phantom variability of 3.5 and 3.8%, respectively, for water and lipid concentrations ranging from 15 to 85%. The
phantoms were long-lasting and exhibited water and lipid fractions that were consistent to within 5% of their
original content when measured 2 weeks after creation. A breast-shaped three-compartment model of adipose,
fibroglandular, and malignant tissues was created with water content ranging from 30% for the adipose simulant
to 80% for the tumor. Mean measured water content ranged from 30% in simulated adipose to 73% in simulated
tumor with the higher water localized to the tumor-like material. This novel heterogeneous phantom design is
composed of physiologically relevant concentrations of the major optical absorbers in the breast in the
near-infrared wavelengths that should significantly improve imaging system characterization and optimization
because the materials have stand-alone structural integrity and can be readily molded into the sizes and
shapes of tissues commensurate with clinical breast imaging. © 2014 Society of Photo-Optical Instrumentation Engineers
(SPIE) [DOI: 10.1117/1.JBO.19.2.026012]
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1 Introduction
Phantoms play a vital role in the development, validation, and
quality control of imaging systems. Clinically, they are recom-
mended for quality management or mandated for technical
surveillance to avoid system malfunction and possible adverse
effects on patients undergoing examination. In research and
development, phantoms are used for early-stage feasibility test-
ing and performance evaluation; they assist in diagnosing errors
or underperforming instrumentation, and enable comparisons of
data acquired on different imaging systems.
Phantom measurements have certainly been an important
part of the development of near-infrared (NIR) spectral tomog-
raphy (NIRST). NIR light (600 to 1000 nm) is preferentially
absorbed by hemoglobin, water, and lipids—tissue chromo-
phores that are often altered in the presence of malignancy.1–5
Thus, breast imaging using NIRST has been studied extensively,
and imaging systems deployed clinically often incorporate
a homogeneous calibration phantom. These phantoms provide
information on imaging system accuracy by offering an exper-
imental environment where known chromophore concentrations
in the phantom can be compared to their recovered (imaged)
counterparts, which in turn improves confidence during breast
imaging when comparisons to known values are not possible.
Phantoms are typically used in validation studies of system
accuracy and repeatability, and can be constructed from resins or
plastics. They should be long lasting, homogeneous, durable,
and possess optical properties similar to tissue. Extensive
work has been reported on the development of these types of
phantoms, and several papers review the different materials
and scattering agents that are available.6,7 Measurements from
these phantoms should be highly repeatable so that any changes
in the data can be attributed to changes in the system. At present,
commercial companies exist that produce customized homo-
geneous phantoms with tissue-like optical properties in a wide
range of sizes and material options.8
A second type of optical phantom, referred to as an anthropo-
morphic phantom, is intended to mimic the breast more closely
in both physical shape and tissue composition. It is important for
investigating an NIRST system’s ability to recover tissue chro-
mophores in different concentrations, locations, and sizes within
a heterogeneous volume of material with a scale similar to the
breast. These phantoms assist in the optimization of data collec-
tion and image reconstruction for a given imaging system, as
well as in determining which patient populations are most likely
to benefit from the technique. Similar to system validation phan-
toms, durability and repeatability are important. However, main-
taining a spectral absorption profile and absorber concentrations
similar to those in the tissue of interest is paramount to success
in developing an anthropomorphic phantom. To mimic the
breast closely, they should be composed of hemoglobin, water,
and lipids in varying physiological concentrations and have
their central zones more similar to fibroglandular tissue and
their outer areas more representative of adipose tissue in con-
cordance with the typical breast parenchymal pattern.9
Previous breast-simulating phantoms have been constructed
from hemoglobin, water, and intralipid.10 The latter is typically
added not to mimic breast lipid content, but to create optical
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scattering. Thus, it is used in low concentrations by volume
(∼1%). These phantoms effectively emulate the tissue optical
properties of oxyhemoglobin, and in some cases, deoxyhemo-
globin, but they do not represent physiologically relevant water
or lipid contents due to their low intralipid percentage.11–13
Development of physiologically relevant water and lipid
phantoms is especially important for evaluating NIR imaging
systems that incorporate wavelengths >900 nm,14–16 where
absorption by these chromophores is more significant than at
lower wavelengths where the hemoglobin absorption dominates.
Water and lipids are not only the main absorbers at longer opti-
cal wavelengths; they also comprise the bulk of breast tissue
volume. Accordingly, several groups have described the devel-
opment of water and lipid phantoms. For example, Merritt
et al.17 correlated a series of water and lipid fractions with
magnetic resonance imaging and diffuse optical tomography.
Nachabé et al.18 analyzed water and lipid contents at higher
wavelengths. Most recently, Quarto et al.19 characterized several
recipes for phantoms composed of water and lipids with three
different emulsification agents.
In this paper, a robust method is reported for creating semi-
solid phantoms with physiologically relevant water and lipid
volume fractions that have sufficient structural integrity to
stand alone. The free-standing character of these phantoms elim-
inates the confounding effects of light channeling from a hous-
ing container6 and allows anthropomorphic breast shapes and
sizes to be created. The breast is typically composed of adipose
tissue, ∼81% on average,20 and although adipose tissue is not
100% lipids, it does have a lipid fraction up to 85%;21 hence,
the most accurate breast phantoms should have high lipid con-
tent. Here, we investigate the creation of phantoms with lipid
contents >70% in a free-form geometry. A major focus is
the systematic examination of emulsifiers to provide the physi-
cal scaffolding necessary to create anthropomorphic free-stand-
ing phantom structures. Combining water and lipid-based
phantoms with hemoglobin is also important. Thus, ease of cre-
ation, durability, reproducibility, and cost and accessibility of
materials are additional factors that served as driving forces
for the development of this new optical breast tissue phantom.
2 Materials and Methods
2.1 Phantom Creation
2.1.1 Material testing
The most effective phantom recipe was found by testing differ-
ent combinations of lipid, emulsifier, and water. Water was
mixed with butter, margarine, olive oil, canola (rapeseed) oil,
Crisco® (vegetable oil), and lard. For each of these combina-
tions, a different emulsifier was used: guar gum, soy lecithin,
and borax (sodium borate). These emulsification agents were
selected because they are ubiquitous, inexpensive, and nontoxic.
The components were mixed using a common blender. The
liquid mixture was then poured into a small plastic container
and refrigerated overnight. Different ratios of fat to water phan-
toms were created: 30∶70; 40∶60; 50∶50; 60∶40, and 70∶30,
and tested with different concentrations of emulsifiers. These
phantoms were then inspected for their malleability and homo-
geneity. The purpose of these studies was to ensure that semi-
solid models could be constructed from a wide range of water
and lipid combinations that simulate actual breast tissue.
To determine how the different emulsification agents altered
the optical absorption characteristics of the water and lipid
combinations, they were mixed separately with liquid (heated)
Crisco and water and imaged in a spectrophotometer from
600 to 1000 nm.
2.1.2 Water and lipid only phantoms
After experimenting with a number of lipids and emulsifying
agents, lard and guar gum were selected and used in all of
the following studies. Combinations of 15∶85, 25∶75, 30∶70,
65∶35, 60∶40, and 50∶50 by volume of water:lipids (and
vice versa) were measured. Initial work (not shown) involved
mixtures closer to 50∶50 in content. After satisfactory results
were obtained in these cases, phantoms were created that had
more extreme water and lipid fractions than are reported
here. Additionally, several identical phantoms were constructed
using the same procedure to test the repeatability of the pro-
cedure, and some phantoms were imaged longitudinally to
assess their longevity at time points separated by 2 weeks
where the phantom was stored in a dark refrigerator between
imaging sessions.
The procedure for creating these phantoms is illustrated in
Fig. 1. First, lard was heated until melted (38°C 2°C), and
then it was added to a mixture of water and 3% guar gum
by weight. A handheld, automated mixer was immediately
used to stir the ingredients at low and then medium speed set-
tings. This mixture was then poured into containers that were
covered in plastic wrap. The phantoms were refrigerated over-
night to solidify before being tested with a diffuse optical
spectroscopic imaging (DOSI) system.22 In many cases, these
phantoms were imaged the following day with no additional
modifications; however, for thicker and larger phantoms,
manual mixing using a handheld potato masher was required.
Each measurement takes ∼2 s, and the phantoms were measured
multiple times at different locations to assess heterogeneity.
All scans were performed at room temperature.
Fig. 1 Schematic of the phantoms creation process.
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2.1.3 Anthropomorphic phantoms
To create a more anthropomorphic phantom, different compo-
nents were designed to represent fat, fibroglandular tissue,
and tumor, where the first two layers were incorporated into
a breast shape mold. Porcine blood was added to phosphate-buf-
fered saline to introduce hemoglobin content. Once the lard was
melted, guar gum was added to the blood mixture, and immedi-
ately afterward, lard was added while mixing with handheld
beaters. The tumor inclusion was formed in a 115-mL container
with 80∶20 water:lipid ratio and 3% by weight guar gum with
30 μM Hb. To construct the layer representing fibroglandular
tissue, a 70∶30 water:lipid phantom with 3% by weight guar
gum and 20 μM Hb was made having a total volume of
1400 mL. The thickness of this layer was ∼4.5 cm. To form
the layer that represented fat, a 30∶70 water:lipid phantom of
total volume 360 mL was made with 3% by weight guar
gum and 10 μM Hb. It was 1.3 cm thick. All of the phantoms
were refrigerated after mixing. In the case of an anthropomor-
phic phantom, the remixing step was not necessary because the
layers of different compositions were thinner than in the water
and lipid only phantoms. Some mixing was performed in the
process of adding the tumor inclusion to the fibroglandular
layer, as some of the fibroglandular material was removed so
that the tumor region could be added.
An anthropomorphic breast-shaped phantom with three dis-
tinct tissue regions was imaged in a grid pattern similar to the
one used for patient imaging with the DOSI system.22 The grid
pattern consisted of 36 measurement points, each separated by
1 cm in x and y directions and spanning 5 × 5 cm across the
phantom. First, just the fibroglandular-like tissue layer was
imaged, then a section 2 cm in depth and diameter was removed
from the phantom and replaced with the tumor-like material.
The entire phantom was reimaged with measurements acquired
from the same positions. Last, a layer of adipose simulating tis-
sue was placed on top of the fibroglandular/tumor layer and the
grid pattern of images was repeated.
2.2 Imaging System
Measurements were obtained on a DOSI system, currently on
loan from the University of California at Irvine as part of a mul-
ticenter clinical trial.23,24 This system possesses both frequency
domain and continuous imaging capabilities, which characterize
reduced scattering coefficient and absorption across the NIR
spectral bandwidth (650 to 1000 nm). The frequency domain
components use six distinct wavelengths from 650 to
850 nm, sweeping through modulation frequencies from 50
to 600 MHz with light detected via avalanche photodiodes.
The continuous wave portion of the DOSI data samples the
tissue at 1024 wavelengths between 580 and 1020 nm spaced
∼0.5 nm apart using a broadband white light source and
a CCD spectrophotometer. Measurements obtained with this
system are reported to be accurate to 0.0006 mm−1 for the
absorption coefficient and 0.03 mm−1 for the reduced scattering
coefficient.25 For the absorption and scattering properties of the
phantoms studied here, this accuracy is equal to an error of ∼5%
in these parameters.
The sample interface is a handheld probe with a fixed-source
detector separation of 28 mm. A series of phantom measure-
ments were recorded for calibration prior to sample measure-
ments.26 For initial experiments, the measurement probe was
placed directly on the phantom surface and was cleaned after
each measurement. Later, phantoms were wrapped in a very
thin layer of plastic to prevent direct contact with the handheld
imaging probe. Comparisons of measurements in phantoms
with direct contact versus plastic covering showed negligible
differences.
2.3 Data Reconstruction
A power law fit of the data for the reduced scattering coefficients
measured at selected wavelengths defines the scattering proper-
ties across the measured range. Chromophore concentrations
were calculated using the Beer–Lambert law for the measured
absorption coefficients. Molar extinction values for hemoglobin,
deoxyhemoglobin, water, and lipids27–29 were used in this proc-
ess. Water and lipid fractions were constrained to 100%, and
hemoglobin absorption was not considered for the phantoms
composed exclusively of water, lard, and emulsifier, but was
included for the anthropomorphic phantoms containing porcine
blood.
3 Results
3.1 Creation of Optimal Phantoms
In creating semisolid phantoms consisting of water and lipids,
lipid and emulsifying agents were tested across a range of
physiologically relevant water to lipid ratios (30∶70 to 70∶30)
as shown in Fig. 2(a). The amount of emulsifying agent was kept
constant for a given volume of phantom to ensure that its effect
on optical properties would not vary across different phantom
concentrations. As expected, phantoms comprised mostly of
water were more gelatinous than phantoms comprised mostly
of lipids.
When guar gum was used, all phantoms were semisolid and
visually homogeneous. Additionally, guar gum had the lowest
signal attenuation in spectrophotometry measurements in the
NIR regime of any of the emulsifying agents presented here
(data not shown). Thus, it appeared to be the most viable emul-
sifier for water and lipid phantoms. Several lipid dominant
materials underwent spectrophotometry analysis in the NIR
range, and Crisco (vegetable oil) and lard (porcine fat) matched
published absorption spectra.28,30 Ultimately, lard was selected
for the phantoms as the types and percentages of fatty acid
were more similar in the animal fat than the vegetable oil.31
Despite the addition of an emulsification agent to these phan-
toms, water and lipid peaks were clearly discernable as shown
in Fig. 2(c). The lipid absorption peak is evident in the left
graph as a sharp rise around 930 nm, while the water absorption,
highlighted in the right graph, has a broad peak above 950 nm
that extends to ∼1000 nm. The average scattering amplitude of
0.66 · 10−3λmb−1 and average scattering power of 0.42 of the
lard-based phantom are on the low end of values found in human
subjects.32
3.2 Contrast Sensitivity
Linear contrast recovery of water and lipids was found when
measuring several water:lipid ratios from 15∶85 to 85∶15,
roughly the physiologic limits for the macroscopic tissues
probed by diffuse optical techniques.21 These results are
shown in Fig. 3 with an R2 of 0.998 for the linear fit. Each phan-
tom was measured at 10 distinct locations, and the mean stan-
dard deviation of these measurements was 3.5%. However,
as noted by other groups,17,19 lipid content is overestimated,
Journal of Biomedical Optics 026012-3 February 2014 • Vol. 19(2)
Michaelsen et al.: Anthropomorphic breast phantoms with physiological water, lipid, and hemoglobin content. . .
especially for high lipid ratios. Visual inspection of these phan-
toms showed a color gradient as observed in the photograph in
Fig. 4, and measurements along the side of this phantom dem-
onstrated a decrease in lipid content from the top to the bottom.
These phantoms were subsequently remixed manually and then
remeasured. The recovered water and lipid content were again
linear with an R2 of 0.96, but with recovered values within 2.5%
of their actual values on average as shown by the dashed line in
Fig. 3. They maintained homogeneity as well with an average
standard deviation of 4.1%. The phantom constituents do not
separate after manual remixing as long as the phantoms, once
fully formed, are maintained at room temperature or colder, so
only a single remixing step is required.
3.3 Reproducibility
In order to test the reproducibility of the phantom creation proc-
ess, three phantoms composed of the same volume of water,
Fig. 2 (a) Several early phantom creations comprised 70% lipid and 30% water. The fats were butter,
olive oil, Crisco, and canola oil (left to right). The first and third phantoms included guar gum as the
emulsifier, while the second and fourth utilized soy lecithin. (b) The chemical formula for guar gum34.
(c) Data from the diffuse optical spectroscopic imaging system for a mostly lipid (left) and mostly water
(right) phantom. The top graph shows the scattering data and fits, while the bottom graph shows the
absorption results. Specific peaks for lipids and water can be discerned above 900 nm.
Fig. 3 Graphs of measured water (a) and lipid (b) fractions with (round) data points and standard devia-
tions based on 10 measurements from the top of the phantoms. The dotted line is a linear fit for the
phantomswith the higher water content before mixing, exhibiting good linearity. The x-shaped data points
and corresponding dashed linear fit for the high lipid content phantoms were obtained after their materials
were manually mixed. The solid line depicts the actual water or lipid content.
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lard, and guar gum were fabricated. Each phantom was created
by independently following the steps shown in Fig. 1, but all
three used ingredients from the same containers and were
made by the same individual. The results of this study are
shown in Fig. 4(c). The recovered lipid contents were 60.7,
59.7, and 65.0% for the three samples and had intraphantom
standard deviations of 1.97, 1.60, and 4.72%, respectively,
and interphantom standard deviation of 3.81%.
3.4 Durability
Phantoms were evaluated at a variety of time points after initial
creation. Because of the need for cooling, no phantoms were
tested without at least 4 h of refrigeration. Three phantoms
with 15∶85, 25∶75, and 35∶65 water:lipid contents were tested
after 2 weeks of refrigeration. At the time of creation, the recov-
ered lipid content was 87.9, 72.1, and 65.8%, respectively. Two
weeks later, the values were 87.3, 79.7, and 64.3%, respectively.
After an additional week of refrigeration, some phantoms devel-
oped mold, indicating that with proper refrigeration these phan-
toms may last for several weeks.
3.5 Anthropomorphic Test Case
The average water content of the fibroglandular simulating layer
was measured as 54.9%, 72.8% for the tumor layer prior to
insertion in the multilayer phantom, and 29.5% for the adipose
layer. As shown in Fig. 5, the tumor inclusion was recovered
with 16% greater water content when compared to the fibro-
glandular region. The actual tumor water content was 10%
greater than its fibroglandular counterpart. The adipose region
was recovered with a water content within 0.5% of the actual
amount. After the tumor region was included in the phantom,
measurements in that area showed higher water content and
lower lipid content than the surrounding measurement points.
Additionally, after the adipose layer was placed on top of the
other two, measured water content decreased and lipid content
increased as expected. Hemoglobin recovery was 33.2, 25.5,
and 8.2 μm for the tumor, fibroglanduar, and adipose regions,
respectively, relative to the actual amount of hemoglobin added,
i.e., 30, 20, and 10 μm Hb in each of the three tissue types.
4 Discussion
After testing several types of emulsification agents and lipids,
guar gum and lard were selected as the ideal constituents for
creating breast mimicking phantoms. Lard was preferable,
as animal fat is likely more similar to the adipose content
in human tissue relative to vegetable-oil-based products.
However, the percent of different types of fatty acids contained
in the lard can change depending on the animal’s diet and the
part of the animal from which the fat was contributed.33
Regardless, changes in the near-infrared absorption due to
different fatty acid composition are very small,31 indicating
that both Crisco and lard could be used depending on their
availability. To minimize the effects of impurities, all samples
produced on a given day were constructed from the same
batch of melted lard.
Guar gum showed the lowest absorption in spectrophotom-
etry studies and had the greatest thickening power and homo-
geneity in phantom formation—characteristics that can be
understood from its molecular structure. Guar gum is a high
molecular weight polysaccharide composed of highly branched
galactose and mannose units.34 The chemical formula for guar
gum is shown in Fig. 2(b). Additionally, examinations of the
absorption spectra of phantoms composed of water, lipids, and
emulsifier exhibited easily discernable peaks for their water and
lipid constituents as shown in Fig. 2(c), and accurate chromo-
phore recovery occurred as demonstrated in Fig. 3.
Water and lipids do not mix spontaneously, but vigorous
mixing can create an emulsion, although the two will separate
again shortly thereafter. The large size and abundance of
branches and hydroxyl groups on the guar gum creates bonds
that decrease molecular movement after mixing, thus creating
a stable emulsion that is thickened and more solid than the liquid
components. Last, cooling after mixing further inhibits separa-
tion of water and lipids, and enhances the solidity of the phan-
tom. The final product is moldable, and retains its shape after
application of minimal pressure.
This process is not infallible, as some separation of lipid and
water may occur as the phantom begins to solidify, causing the
linear concentration gradients shown in Fig. 4. The effect is
a result of the time delay between the mixing and solidifica-
tion of the phantom. Procedures exist to mitigate these effects.
One method is postrefrigeration manual mixing, which was
Fig. 4 (a) Photograph showing visible differences between the top (left) and bottom (right) of the phan-
tom. (b) Corresponding depth-dependent measurements confirming the greater presence of lipids at
the top of the phantom and higher water at the bottom of the phantom. (c) Repeatability of the phantom
creation process in three independently constructed phantoms with the same water and lipid ratio, each
measured five times.
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very successful as shown in the data and dashed line in Fig. 3,
and significantly improved the accuracy of the water and lipid
quantification of the mixed material when compared to the same
measurements on the unmixed material. Mixing techniques can
have an impact on the final phantom outcome. Manual mixing
involves slow, gentle compression of the materials at room
temperature by hand for a few minutes (the amount of time
can vary depending on the size of the phantom), not at high
speed, as blending the solid phantom may introduce air bubbles
that would alter the desired optical properties. When different
individuals mixed the same phantom, average differences in
measured water and lipid content were <5%.
Other steps that could be taken include minimizing the height
of the phantom, mixing the heated lipids with cold water to
decrease the time for solidification, or cooling the mixture
more quickly. The first strategy was successful when making
the thin adipose layer, whereas the other approaches were not
investigated in this study, but would likely improve results in
future phantom experiments.
These phantoms possess intrinsic scattering properties result-
ing from their water and lipid interfaces, which change with
concentration. Specifically, higher fat content leads to greater
scattering. This behavior is opposite to the scattering found
in breast tissue, possibly because tissue water is mostly
found within cells that also possess a number of light scattering
organelles, whereas these phantoms are composed of pure water
with no additional scatterers. Differences in scattering, in addi-
tion to differences in absorption, are accounted for in the fre-
quency domain instrumentation.
Despite this water-lipid separation issue, creating durable,
homogeneous, repeatable semisolid phantoms across a broad
range of water-to-lipid ratios with easily accessible ingredients
and tools was demonstrated. Inter- and intraphantom variability
was <5%. The phantoms do not break and can be remolded into
different shapes as needed, unlike agar or gelatin materials that
often crack. They can be compressed with manual force (more
easily for higher water content but possible at all compositions),
unlike hard resin phantoms. Phantoms measured 2 weeks after
creation exhibited water and lipid contents within 5% of their
originally measured concentrations. Their semisolid consistency
eliminates the complexities of imaging phantoms within con-
tainers where light channeling may occur. These phantoms
Fig. 5 (a) Schematic of a free-standing three-compartment phantom and the grid pattern used to assess
its optical properties. A given phantom was evaluated at 36 locations on a 1-cm grid pattern as shown.
Interpolated results across the 5 × 5 cm grid of individual measurements of optical properties are
shown for water in (b) and lipids in (c) in the fibroglandular, tumor, and adipose regions. In the top row,
the fibroglandular-simulating phantom was measured alone. The middle row depicts results when
a tumor-like inclusion of ∼2 cm diameter was added near 20 to 40 mm in x and 60 mm in y directions.
In the bottom row, measurement data are shown when a uniform adipose simulating layer was added on
top of the fibroglandular and tumor phantom. Photographs of the phantom regions are shown in (d).
Journal of Biomedical Optics 026012-6 February 2014 • Vol. 19(2)
Michaelsen et al.: Anthropomorphic breast phantoms with physiological water, lipid, and hemoglobin content. . .
were inexpensive to construct, costing <5.00 per 700 mL of
phantom material, and all of the ingredients and equipment
could be purchased at a local grocery store.
An anthropomorphic breast-shaped phantom with three dis-
tinct tissue regions was studied as a test case. It contained the
three main light absorbers in the NIR—hemoglobin, water, and
lipid—and possessed intrinsic scattering properties, albeit on
the lower end of what is expected for human breast because its
materials do not contain human cells or organelles. Because
the melting point of lard is well below the temperature of hemo-
globin denaturation, blood can easily be incorporated into this
phantom.35 Adding hemoglobin to the water and lipid phantoms
did not substantially alter their water and lipid fractions. Fat
content was overestimated in the fibroglandular and tumor
phantom sections by ∼15 and 8%, respectively, likely due to
the thickness of these compartments (postrefrigeration mixing
was not performed in this case) but was <1% in error in the
adipose layer. The tumor can be localized when added to the
fibroglandular background as shown in Fig. 5. This example
demonstrates the feasibility of producing physiologically
relevant NIR phantoms composed mainly of water, lipid, and
blood that have sufficient structural integrity to be used without
any other supporting containers or fixtures.
5 Conclusions
The phantom process described here can be used to create accu-
rate breast-like optical phantoms with matching biological
composition and physical shape that have sufficient structural
integrity to be used as stand-alone imaging targets. Linear recov-
ery of water and lipid concentrations has been found for com-
positions between 15 and 85% with errors of <5% of the actual
amounts when postrefrigeration mixing was performed. Blood
can readily be added to these phantoms, which are then com-
posed of physiologically relevant percentages of the three
major absorbers in the NIR regime. The phantoms are moldable
and easily shaped by the user. They are also durable, long-last-
ing and repeatable, easy to make, and inexpensive.
Given the positive characteristics of these phantoms, several
areas of research could benefit from their construction. For
example, these phantoms can be used for evaluating imaging
systems that obtain limited spectral information above 900 nm
in order to understand their sensitivity to water and lipid
contrast. Alternatively, a multicompartment phantom model
of different tissue types can be used to test region-based recon-
structions for tomographic imaging systems as well as to assess
signal-to-noise characteristics in an optically heterogeneous
environment. The semisolid character of these phantoms is use-
ful for testing the effects of different breast shapes and sizes on
patient interfaces and at tissue boundaries. Use of these phan-
toms, which closely mimic tissue optical properties, can provide
information to help optimize imaging system development and
determine which patients can be successfully imaged on those
systems.
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